- Home
- VNO vs CORT Comparison
VNO vs CORT Comparison
Compare VNO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNO
- CORT
- Stock Information
- Founded
- VNO 1946
- CORT 1998
- Country
- VNO United States
- CORT United States
- Employees
- VNO N/A
- CORT N/A
- Industry
- VNO Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- VNO Real Estate
- CORT Health Care
- Exchange
- VNO Nasdaq
- CORT Nasdaq
- Market Cap
- VNO 7.0B
- CORT 7.1B
- IPO Year
- VNO N/A
- CORT N/A
- Fundamental
- Price
- VNO $39.63
- CORT $75.08
- Analyst Decision
- VNO Hold
- CORT Strong Buy
- Analyst Count
- VNO 11
- CORT 4
- Target Price
- VNO $38.00
- CORT $142.00
- AVG Volume (30 Days)
- VNO 1.3M
- CORT 1.3M
- Earning Date
- VNO 05-05-2025
- CORT 05-05-2025
- Dividend Yield
- VNO 1.87%
- CORT N/A
- EPS Growth
- VNO 248.25
- CORT 8.36
- EPS
- VNO 0.52
- CORT 1.14
- Revenue
- VNO $1,929,890,000.00
- CORT $685,446,000.00
- Revenue This Year
- VNO N/A
- CORT $35.85
- Revenue Next Year
- VNO $5.12
- CORT $35.22
- P/E Ratio
- VNO $75.54
- CORT $65.80
- Revenue Growth
- VNO 2.98
- CORT 30.93
- 52 Week Low
- VNO $22.42
- CORT $25.35
- 52 Week High
- VNO $46.63
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- VNO 61.90
- CORT 57.68
- Support Level
- VNO $38.63
- CORT $68.86
- Resistance Level
- VNO $40.73
- CORT $73.36
- Average True Range (ATR)
- VNO 1.16
- CORT 3.26
- MACD
- VNO 0.34
- CORT 0.12
- Stochastic Oscillator
- VNO 84.17
- CORT 95.28
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.